|CustomizeUTHR quote (NASDAQ Exchange)
|
| |||||||||||||||||||||||||||||||||||||||||||||||||
Quotes delayed 15 min unless otherwise indicated
Last trade 12:29 PM ET Financial data in U.S. dollars
Your latest quotes: UTHR, TLAB, CA, /MXNUSD, SRE, CVC
Press releasesVideos about UTHR
| |||||||||||||||||||||||||
Stock ratings
More information for UTHR
Financial highlights
| Sales* | 336.79 Mil |
| Income* | -58.36 Mil |
| Sales Growth* | +33.40% |
| Income Growth* | +8.80% |
| Net Profit Margin | -17.33% |
| Debt/Equity Ratio | 0.33 |
* last 12 months
More financial informationFunds that own UTHR
| Fund Name | % Own |
| Pictet Funds (Lux) Biotech | 3.4 |
| Fidelity Magellan Fund | 2.7 |
| Fidelity Select Biotechnology Portfolio | 2.2 |
| View all funds | |
| advertisement |
Market update 9:44am ET
7 things to ask before buying a stock
Putting your money in the market can leave you open to some nasty surprises. Avoid them by doing the right research.
- What's a P/E? (And 9 other 'dumb' questions)
- The lazy person's guide to investing
- 8 costly mistakes investors make
Market Talk With Jim Jubak message board
| advertisement |
- Data providers
- Copyright © 2009 Thomson Reuters. Click for Restrictions.
- Free Real-Time quotes provided by BATS Exchange, Inc.
- Analyst Recommendations data provided by Zacks.com.
- Quotes supplied by Interactive Data Real-Time Services.
- StockScouter data provided by Gradient Analytics, Inc.





